Alnylam Pharmaceuticals, Inc. earnings per share and revenue

ALNY earnings per share for the last quarter are -1.10 USD whereas the estimation was -1.19 USD which accounts for 7.28% surprise. Company revenue for the same period amounts to 439.72 M USD despite the estimated figure of 436.92 M USD. Estimated earnings per share for the next quarter are -1.12 USD, and revenue is expected to reach 428.01 M USD. Also watch annual changes over time to get a bigger picture of ALNY earnings per share and revenue dynamics.